drugset / Press release
New evidence demonstrates early use of Stalevo improves quality of life and may provide long-term benefits in patients with Parkinson's disease
2006-10-31 · Orion Corporation, Orion Pharma · original orionpharma.com ↗
For release content, please refer to the attachment.
The release as fetched from its publisher. orionpharma.com ↗